Skip to main content

Trerotola Matthew L.'s Form 4 filing

Enovis CORP (ENOV) · filed Aug 18, 2021

Accession no.
0001209191-21-052303
Filed
Aug 18, 2021
Trade date
Aug 16, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.42M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Trerotola Matthew L.CIK 0001625057Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2021Common stock, par value $.001MOption exerciseAcquired+150,000$23.74+$3,561,000455,708Direct
Aug 16, 2021Common stock, par value $.001MOption exerciseAcquired+1,446$39.54+$57,174.84457,154Direct
Aug 16, 2021Common stock, par value $.001SSaleDisposed−70,706$48.98F2−$3,463,179.88386,448Direct
Aug 16, 2021Common stock, par value $.001SSaleDisposed−69,710$48.97F3−$3,413,698.7316,738Direct
Aug 16, 2021Common stock, par value $.001SSaleDisposed−5,290$49.49F4−$261,802.1311,448Direct
Aug 16, 2021Common stock, par value $.001SSaleDisposed−4,294$49.50F5−$212,553307,154Direct
Aug 16, 2021Common stock, par value $.001SSaleDisposed−1,446$49.51F6−$71,591.46305,708Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 16, 2021Common stock, par value $.001MOption exerciseDisposed−150,000$0.00$059,563Direct
Aug 16, 2021Common stock, par value $.001MOption exerciseDisposed−1,446$0.00$0537,154Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.46 to $49.46, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.45 to $49.44, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.45 to $49.56, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.46 to $49.56, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $49.53, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)